2013 Media releases
Improved Access of PrONBREZ* BREEZHALER* in Québec, a once-daily bronchodilator for chronic obstructive pulmonary disease (COPD)
Health Canada Approves PrAFINITOR* in Advanced Breast Cancer for Women Battling This Disease
DISCLAIMER FOR ARCHIVES
The information in our Media Release Archives was factually accurate on the date of publication. This information remains on our website for historical purposes only. Novartis Pharmaceuticals Canada Inc. assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon this information as current or accurate after their publication dates.
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
We are a leader in offering medicines to protect health, cure disease and improve well-being.